Feed JAGSNPHARM.BO
JA
Jagsonpal Pharmaceuticals Limited
JAGSNPHARM.BO · BSE
₹231.40 +0.61% (+₹1.40)
1M +1.11%
Market Cap ₹15.2B
P/E Ratio 35.27x
Div. Yield 1.73%
ROE 17.08%
Bulios Fair Price
₹168.31
27.3% downside
Aktuální cena
₹231.4
Podhodnoceno Férová hodnota Nadhodnoceno
Podle Bulios Fair Price je akcie JAGSNPHARM.BO aktuálně nadhodnocená vůči své tržní ceně. Jak to funguje?
Valuation
26 /100
Expensive P/E 35.27x
EV/EBITDA 22.32x
P/S 5.29x
Growth
59 /100
Stable EPS growth 15.64%
Rev. growth 6.66%
FCF growth 0.24%
Profitability
87 /100
Strong Gross margin 63.66%
Net margin 15.00%
Op. margin 16.93%
Quality
78 /100
Excellent ROIC 12.56%
ROE 17.08%
ROA 13.60%
Debt
100 /100
Low Debt/Equity 0.03x
Current ratio 5.06x
Int. coverage 56.95x
Stability
44 /100
Moderate Beta -0.28x
Rev. volatility 20.32%
EPS volatility 93.90%
Zeptejte se StockBota na JAGSNPHARM.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Manish Gupta
Employees
1,025
Headquarters
Gurugram
Nadcházející události
04 ZÁŘ
Ex-Dividend
Ex-dividend date
04 ZÁŘ
Dividend Payment
Datum platby